
Kun Peng International Ltd.
93
Recent news coverage related to Kun Peng International Ltd. is limited and primarily consists of general market and economic topics rather than company-specific developments.
- Recent news includes discussions on Social Security COLA adjustments for 2027, dividend runs for various companies, and market rallies related to crude oil and bond yields, none directly related to Kun Peng International Ltd. [N1][N2][N3][N4][N5][N6][N7][N8]
Kun Peng International Ltd. operates in the healthcare sector, primarily selling consumer health care and health-related household products through retail channels and equipment-based services. The company’s revenue streams include retail sales, equipment-based service revenue from prepaid cards for medical consultations and health screening equipment, technical service revenue, commission revenue, and training revenue. However, some subsidiaries and related business streams were terminated in 2025, impacting revenue composition. The company recognizes revenue upon completion of services or delivery of products. It operates online platforms including King Eagle Mall and Kun Zhi Jian Mini Program. The company has contractual arrangements with variable interest entities (VIEs) and faces potential regulatory restrictions on transferring cash and assets outside of PRC and Hong Kong. As of mid-2026, the company reported liquidity challenges with a low current ratio and net losses continuing in recent quarters.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Kun Peng International Ltd. reported $1.44 million revenue for fiscal 2025, down from $2.08 million in 2024, with a net loss of $1.27 million in 2025. The company’s liquidity as of June 30, 2026 shows a current ratio of 0.04 and cash of $6,606, indicating tight short-term financial resources. The business focuses on consumer health care products and equipment-based services, with recent strategic emphasis on the latter. Operating expenses decreased in 2025 due to deregistration of subsidiaries. The company has not declared dividends and faces potential restrictions on cash transfers due to PRC/Hong Kong regulations.
The company’s strategic shift towards equipment-based services, which showed increased revenue and gross margin in 2025, indicates a potential operational focus that could improve profitability. The reduction in operating expenses due to deregistration of subsidiaries may enhance cost efficiency. The company’s use of online platforms for sales and services could provide scalable channels for customer engagement. Other income gains from disposal of subsidiaries and debt waivers have provided non-operating financial support. These factors suggest areas where the company is managing operational and financial challenges actively.
The company faces significant revenue decline from 2024 to 2025, primarily due to termination of subsidiaries and business streams, indicating operational instability. Liquidity ratios as of June 30, 2026 are very low, with a current ratio of 0.04 and minimal cash, raising concerns about short-term financial health. Continued net losses and negative earnings per share reflect ongoing profitability challenges. Regulatory restrictions on transferring cash and assets outside PRC and Hong Kong may limit financial flexibility. The absence of dividend payments and no plans to declare dividends may affect investor appeal. These factors highlight risks related to financial sustainability and operational continuity.
Kun Peng International Ltd.'s moat appears limited based on available disclosures. The company operates in a competitive healthcare consumer products and services market with no explicit mention of proprietary technology, strong brand differentiation, or significant barriers to entry. Its strategic focus on equipment-based services and online platforms may provide some operational leverage, but the termination of subsidiaries and business streams suggests challenges in maintaining stable revenue sources. Regulatory risks related to cash and asset transfer restrictions in PRC and Hong Kong also constrain operational flexibility. Overall, the company’s moat is not clearly established from public disclosures.
• Liquidity Risk: The company’s current ratio of 0.04 and cash ratio of 0 as of June 30, 2026 indicate limited short-term liquidity, which may constrain its ability to meet current obligations.
• Operational Risk: Termination of subsidiaries and related business streams in 2025 led to significant revenue decline and may reflect challenges in maintaining stable operations.
• Regulatory Risk: Intercompany agreements and VIE contractual arrangements face potential restrictions due to PRC and Hong Kong government regulations on cash and asset transfers, which may impact operational flexibility.
• Profitability Risk: The company reported net losses and negative EPS in recent periods, indicating ongoing challenges in achieving profitability.
• Dividend Policy Risk: No dividends have been declared historically, and the company does not anticipate declaring dividends in the foreseeable future, which may affect investor returns.
Business trends: The company is focusing on equipment-based services with increased revenue share, while overall revenue declined due to subsidiary terminations.
Execution milestones: Deregistration of subsidiaries reduced operating expenses; gains from disposal of subsidiaries and debt waivers improved other income.
Key risks: Liquidity challenges, regulatory restrictions on cash transfers, ongoing net losses, and operational instability from terminated business streams.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Kun Peng International Ltd. operates in the healthcare sector, providing consumer health care and health-related household products primarily through retail and equipment-based services.
- The company recognizes revenue on a gross basis net of VAT and sub-charges.
- Revenue sources include retail sales, equipment-based service revenue (such as prepaid cards for online medical consultation and health screening equipment), technical service revenue, commission revenue, and training revenue, though some streams were terminated in 2025.
- For the fiscal year ended September 30, 2025, total revenue was $1,438,127, down from $2,078,741 in 2024, mainly due to a sharp decrease in retail sales and termination of some subsidiaries and business streams.
- Equipment-based service revenue increased in 2025 compared to 2024, reflecting a strategic focus and promotional initiatives.
- Gross profit for 2025 was $958,295 (66.6% margin), down from $1,473,103 (70.9% margin) in 2024, with retail gross profit decreasing and equipment-based services gross profit increasing.
- Operating expenses decreased from $3,473,901 in 2024 to $2,738,005 in 2025, driven by lower general and administrative and selling expenses due to deregistration of subsidiaries.
- Other income increased significantly in 2025 to $510,797 from $11,538 in 2024, including gains from disposal of subsidiaries and debt waivers.
- As of June 30, 2026, cash and equivalents were $6,606, current assets were $380,900, and current liabilities were $9,994,380, resulting in a low current ratio of 0.04 and a cash ratio of 0, indicating liquidity challenges.
- Net loss for the quarter ended June 30, 2026 was $300,111 with basic and diluted EPS of -$0.008 per share.
- The company has not declared dividends and does not anticipate doing so in the foreseeable future.
- Intercompany agreements and contractual arrangements with variable interest entities (VIEs) exist, with potential restrictions on transferring cash/assets outside PRC/Hong Kong due to government regulations.
- The company’s business model includes online platforms such as King Eagle Mall, Kun Zhi Jian, and a Mini Program for sales and equipment-based services.
- Recent news coverage includes general market and economic topics but no direct company-specific operational news.
- Financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
Generated 2026-08-16
- S1 | 2025-12-31 | 10-K
- S2 | 2026-08-14 | 10-Q
- N1 | 2026-08-16 | www.nasdaq.com | Social Security's Trump Bump-Driven 2027 COLA May Lead to a Silver Lining for the First Time Since 2023 | https://www.nasdaq.com/articles/social-securitys-trump-bump-driven-2027-cola-may-lead-silver-lining-first-time-2023
- N2 | 2026-08-16 | www.nasdaq.com | Walmart Keeps Raising Its Payout No Matter What the Market Does. Here's Why That Matters Now. | https://www.nasdaq.com/articles/walmart-keeps-raising-its-payout-no-matter-what-market-does-heres-why-matters-now
- N3 | 2026-08-16 | www.nasdaq.com | Upcoming Dividend Run For NWL? | https://www.nasdaq.com/articles/upcoming-dividend-run-nwl
- N4 | 2026-08-16 | www.nasdaq.com | Upcoming Dividend Run For CPF? | https://www.nasdaq.com/articles/upcoming-dividend-run-cpf
- N5 | 2026-08-16 | www.nasdaq.com | Upcoming Dividend Run For BEPC? | https://www.nasdaq.com/articles/upcoming-dividend-run-bepc
- N6 | 2026-08-16 | www.nasdaq.com | Upcoming Dividend Run For BIP? | https://www.nasdaq.com/articles/upcoming-dividend-run-bip
- N7 | 2026-08-16 | www.nasdaq.com | Upcoming Dividend Run For BOH? | https://www.nasdaq.com/articles/upcoming-dividend-run-boh
- N8 | 2026-05-20 | www.nasdaq.com | Stocks Rally as Crude Oil and Bond Yields Slump | https://www.nasdaq.com/articles/stocks-rally-crude-oil-and-bond-yields-slump
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


